Vaxcyte, Inc. Common Stock (PCVX) stock analysis and AI prediction
The company facts of Vaxcyte, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Vaxcyte, Inc. Common Stock
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $10.2 billion
- Size
- Large cap
- Employees
- 507
- Headquarters
- SAN CARLOS, CA
- Listed since
- June 12, 2020
- Website
- vaxcyte.com
PCVX questions
What is the AI prediction for PCVX stock?
Each market day our model rates Vaxcyte, Inc. Common Stock (PCVX) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the PCVX prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for PCVX?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see PCVX options?
The PCVX options page opens its calls and puts, with price, volume, implied volatility and the Greeks.